The kernicterus market is experiencing growth, fueled by an increase in neonatal jaundice cases, particularly among preterm infants. Major drivers include advancements in neonatal screening protocols ...

Phototherapy converts bilirubin to soluble forms that can be excreted in the urine. Type 2 disease is less severe, and is treatable using phenobarbital. Before the advent of phototherapy most patients ...

Jaundice in term and near-term (35 to 37 week) infants is generally benign, however, concern has surfaced in recent years regarding reemergence of kernicterus in this patient population. An increasing ...

In July 2003, the National Institute of Child Health and Human Development (NICHD) organized a consensus conference, where a group of experts were invited to review and discuss the current state of ...

ABE is a continuing risk for infants born in the United States and discharged healthy from their birth hospitalization. Clinical controversies regarding the development, diagnosis, and treatment of ...